Exhibiting at Seafood Expo North America 2025

Nippon Suisan Kaisha, Ltd. (Nissui), headquartered in Tokyo, Japan, is one of the world’s largest and most diversified seafood and marine products companies. Founded in 1911, Nissui has over a century of expertise in seafood processing, aquaculture, logistics, biotechnology, and health-focused functional foods. The company operates on a truly global scale, with production and distribution networks spanning Asia, Europe, North and South America, and Oceania.

Company Background

Nissui was established with the goal of developing Japan’s fishing and marine resources industry and has since grown into a global food conglomerate. Over the decades, Nissui has expanded its operations across all segments of the marine food value chain—from ocean fishing fleets and aquaculture farms to frozen and shelf-stable food production and fine chemical synthesis.

Nissui is listed on the Tokyo Stock Exchange (TSE: 1332) and is part of the Nikkei 225 Index.

Core Business and Product Range

Nissui’s product portfolio is broad and spans multiple verticals:

• Frozen Prepared Foods:

  • Breaded seafood (e.g., shrimp cutlets, white fish fillets)
  • Frozen bento meals
  • Ready-to-heat seafood dishes for retail and foodservice

• Shelf-Stable Foods:

  • Canned mackerel, tuna, and sardines
  • Retort pouch seafood meals

• Surimi-Based Products:

  • Fish sausages
  • Crab-flavored sticks (kanikama)
  • Other seafood analogs for sushi, salads, and hot pot dishes

• Aquaculture Products:

  • Farm-raised salmon, yellowtail, and bluefin tuna
  • Aquaculture feeds and fry development

• Functional and Health Foods:

  • Nutraceuticals enriched with omega-3 fatty acids (EPA/DHA)
  • Supplements and fortified food ingredients

• Fine Chemicals:

  • EPA and DHA omega-3 fatty acids for pharmaceutical and food use
  • Industrial enzymes and specialty chemicals derived from marine resources

Specialization and Unique Selling Proposition

Nissui's core strengths lie in its:

• Vertical integration across the entire marine food value chain
• Global manufacturing and distribution footprint, including subsidiaries in the U.S. (Unisea, Gorton’s), Chile (Salmones Antártica), and Europe
• Advanced biotechnology capabilities, enabling the development of functional marine lipids and pharmaceutical-grade EPA
• Commitment to sustainability, reflected in active participation in global initiatives like the Global Sustainable Seafood Initiative (GSSI) and Marine Stewardship Council (MSC) certification programs

Financials and Market Footprint

As of FY 2023 (ending March 2023), Nissui reported:

• Revenue: ¥744.9 billion (~$5.3 billion USD)
• Operating Profit: ¥33.5 billion (~$240 million USD)
• Net Income: ¥26.7 billion (~$190 million USD)
• Overseas sales accounted for more than 30% of total revenue

Nissui operates production bases in over 25 countries and sells products in over 80 markets globally. It has over 10,000 employees worldwide.

Shipment and Export Data

Based on public export data and import-export platforms:

• Nissui’s subsidiaries collectively account for thousands of TEUs annually in processed seafood exports
• Key export products include frozen seafood, surimi blocks, tuna loins, and omega-3 concentrates
• Major importing markets include the United States, China, South Korea, EU countries, and Latin America

Nissui is also a major raw material supplier to other food manufacturers under white label or bulk ingredient arrangements.

Target Market

Nissui caters to a broad spectrum of customers:

• Retail chains looking for frozen seafood meals and canned goods
• Foodservice companies sourcing bulk seafood for institutional catering
• Pharmaceutical and nutraceutical firms requiring EPA and DHA extracts
• Industrial food producers needing base ingredients like surimi and fish protein
• Aquaculture companies purchasing fry, feeds, or technical support

Their global customer base includes leading supermarket chains, supplement brands, and global QSR (quick-service restaurant) suppliers.

Capabilities

• Aquaculture R&D centers in Japan and South America
• State-of-the-art production plants for frozen and canned seafood
• High-efficiency extraction facilities for marine-derived functional lipids
• Regulatory compliance across regions, including FDA, EFSA, and PMDA approvals

Their innovations include enzymatic hydrolysis for fish protein concentrates and microencapsulation of omega-3s for stability in food and beverage applications.

Certifications and Compliance

Nissui adheres to international safety and environmental standards:

• HACCP and ISO 22000 for food safety
• MSC and ASC Certifications for sustainable seafood sourcing
• GMP and FSSC22000 for pharmaceutical-grade production
• Sedex and SMETA-compliant operations for ethical labor practices
• EU and FDA-compliant production facilities

The company is a member of the International Fishmeal and Fish Oil Organisation (IFFO) and aligns its operations with the UN Sustainable Development Goals (SDGs).

Customer Testimonials

“Nissui has been our trusted supplier for nearly a decade. Their frozen seafood quality is consistently top-tier, and their innovation in value-added formats helps us stay competitive.” — Procurement Manager, EU Retail Chain

“Their EPA/DHA concentrates are second to none. As a health supplement brand, Nissui’s marine lipids have become core to our cardiovascular product line.” — CEO, Nutraceutical Firm, USA

Major Achievements

• Pioneer in commercial surimi production since the 1960s
• Introduced Japan’s first EPA pharmaceutical approved by PMDA
• Awarded multiple times for Sustainability and SDG alignment in food industry rankings
• Ranked among Top 5 global seafood companies by annual revenue
• Developed traceable aquaculture systems for premium bluefin tuna

Nissui continues to lead the global marine food and biotechnology sectors by combining traditional seafood expertise with cutting-edge innovation in health and sustainability.